Literature DB >> 28700433

Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

W Glenn McCluggage1, Meagan J Judge, Isabel Alvarado-Cabrero, Máire A Duggan, Lars-Christian Horn, Pei Hui, Jaume Ordi, Christopher N Otis, Kay J Park, Marie Plante, Colin J R Stewart, Edwin K Wiredu, Brian Rous, Lynn Hirschowitz.   

Abstract

A comprehensive pathologic report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but the content of these is variable. The International Collaboration on Cancer Reporting is an alliance formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer and the European Society of Pathology, for the purpose of developing standardized, evidence-based reporting data sets for each cancer site. This will reduce the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish and maintain standardized cancer-reporting data sets. The resultant standardization of cancer-reporting benefits not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets. We describe the development of an evidence-based cancer data set by the International Collaboration on Cancer Reporting expert panel for the reporting of primary cervical carcinomas and present the "required" and "recommended" elements to be included in the pathology report as well as an explanatory commentary. This data set encompasses the International Federation of Obstetricians and Gynaecologists and Union for International Cancer Control staging systems for cervical neoplasms and the updated World Health Organization classification of gynecologic tumors. The data set also addresses controversial issues such as tumor grading and measurement, including measurement of multifocal carcinomas. The widespread implementation of this data set will facilitate consistent and accurate data collection, comparison of epidemiological and pathologic parameters between different populations, facilitate research, and hopefully result in improved patient management.

Entities:  

Mesh:

Year:  2018        PMID: 28700433     DOI: 10.1097/PGP.0000000000000412

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  12 in total

Review 1.  [The 2019 FIGO classification for cervical carcinoma-what's new?]

Authors:  L-C Horn; C E Brambs; S Opitz; U A Ulrich; A K Höhn
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

Review 2.  The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines.

Authors:  Maria Rosaria Raspollini; Sigurd F Lax; W Glenn McCluggage
Journal:  Virchows Arch       Date:  2018-05-24       Impact factor: 4.064

Review 3.  Intraoperative imaging in pathology-assisted surgery.

Authors:  Floris J Voskuil; Jasper Vonk; Bert van der Vegt; Schelto Kruijff; Vasilis Ntziachristos; Pieter J van der Zaag; Max J H Witjes; Gooitzen M van Dam
Journal:  Nat Biomed Eng       Date:  2021-11-08       Impact factor: 25.671

Review 4.  [Revised German guidelines on the diagnosis and treatment of carcinoma of the uterine cervix-what's new for pathologists in 2021?]

Authors:  Lars-Christian Horn; Matthias W Beckmann; Markus Follmann; Martin C Koch; Monika Nothacker; Birgit Pöschel; Frederik Stübs; Dietmar Schmidt; Anne Kathrin Höhn
Journal:  Pathologie (Heidelb)       Date:  2022-02-21

Review 5.  [TNM classification of gynecologic malignancies : What remains to be done beyond 2017?]

Authors:  L-C Horn; C E Brambs; S Opitz; J Einenkel; D Mayr
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

6.  Towards developing a meaningful grading system for cervical squamous cell carcinoma.

Authors:  W Glenn McCluggage
Journal:  J Pathol Clin Res       Date:  2018-03-30

Review 7.  Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.

Authors:  Kay J Park; Andres Roma; Naveena Singh; C Blake Gilks; Esther Oliva; Nadeem Abu-Rustum; Pedro T Ramirez; W Glenn McCluggage
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

Review 8.  Grading of Endocervical Adenocarcinomas: Review of the Literature and Recommendations From the International Society of Gynecological Pathologists.

Authors:  Karen L Talia; Esther Oliva; Joseph T Rabban; Naveena Singh; Simona Stolnicu; W Glenn McCluggage
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

Review 9.  Endocervical Adenocarcinoma, Gross Examination, and Processing, Including Intraoperative Evaluation: Recommendations From the International Society of Gynecological Pathologists.

Authors:  Carlos Parra-Herran; Anais Malpica; Esther Oliva; Gian Franco Zannoni; Pedro T Ramirez; Joseph T Rabban
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

Review 10.  [Reporting and handling of lymphonodectomy specimens in gynecologic malignancies and sentinel lymph nodes].

Authors:  Anne Kathrin Höhn; Christine E Brambs; Ramona Erber; Grit Gesine Ruth Hiller; Doris Mayr; Dietmar Schmidt; Elisa Schmoeckel; Lars-Christian Horn
Journal:  Pathologe       Date:  2021-05       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.